From left, United HomeCare Chairman Ricardo Garcia, Pascal J. Goldschmidt, M.D., and Carlos L. Martinez.
Dean Pascal J. Goldschmidt, M.D., was honored with the Education/Advocacy Award at the 2015 United HomeCare Annual Dinner on May 14. The award is one of the Claude Pepper Awards — named for the late U.S. Senator from Florida who fought for the rights and the welfare of the elderly and the poor — given out each year to celebrate the achievements of exceptional individuals who exemplify Pepper’s spirit and ideals.
“As you know, Senator Claude Pepper was a tireless advocate for the elderly throughout his public service career,” Goldschmidt said. “He understood that health care in the home and community is indispensable to the well-being of older Americans. The ideals he stood for mirror our common purpose at the University of Miami Miller School of Medicine.
Read more about Dean Goldschmidt's award »
From left, Ivan Jozic, Ph.D., Marjana Tomic-Canic, Ph.D., Irena Pastar, Ph.D., Horacio Ramirez, Ashley Marie Rosa and Stephen C. Davis.
A team of researchers from the Miller School of Medicine’s Department of Dermatology and Cutaneous Surgery had a strong presence at the recent annual meeting of the Wound Healing Society and Symposium of Advanced Wound Care. The department is a national leader in the field, a standing that was demonstrated by some of the honors earned at the meeting.
Marjana Tomic-Canic, Ph.D., professor of dermatology and Director of the Wound Healing and Regenerative Medicine Research Program, became President-Elect of the Society, a position she will officially assume at the 2016 annual meeting.
Read more about the wound healing meeting »
From left, Pascal J. Goldschmidt, M.D., Alan Pollack, M.D., Ph.D., Erin Kobetz, Ph.D., M.P.H., Arul M. Chinnaiyan, M.D., Ph.D., Ronald C. Desrosiers, Ph.D., Diana Lopez, Ph.D., Jonathan C. Trent, M.D., Ph.D., Vinata B. Lokeshwar, Ph.D., and Stephen D. Nimer, M.D.
Six Miller School of Medicine physician-scientists were recognized for their contributions to cancer research and treatment as part of the Sylvester Comprehensive Cancer Center’s 16th Annual Zubrod Memorial Lecture and Cancer Research Poster Session on May 15. It was the first time multiple faculty awards have been part of the program.
Stephen D. Nimer, M.D., Sylvester’s Director, hosted the afternoon-long event, whose featured speaker was Arul M. Chinnaiyan, M.D., Ph.D., a Howard Hughes Medical Institute Investigator, American Cancer Society Research Professor, and S.P. Hicks Endowed Professor of Pathology and Urology at the University of Michigan.
Read more about the program »
Ralph L. Sacco, M.D., M.S.
Ralph L. Sacco, M.D., M.S., was honored with the Johann Jacob Wepfer Award at the 24th annual European Stroke Conference. Named for Johann Jacob Wepfer (1620 –1695), the first physician to hypothesize that the effects of a stroke were caused by bleeding in the brain, the award recognizes Wepfer’s accomplishments as a pathologist and pharmacologist. The award is presented annually to a scientist whose outstanding scientific work in the field of cerebrovascular diseases significantly contributes to knowledge about treatment of acute stroke.
Only two other U.S. stroke researchers have received this honor since the award’s inception in 2005. Michael G. Hennerici, M.D., President of the European Stroke Research Foundation, said that Sacco was selected to receive the award because of his outstanding clinical and research work in the fields of stroke management and stroke prevention, with a particular view to associated comorbidities.
Read more about the award »
Susanne Doblecki-Lewis, M.D., Rosemary Iwunze, M.D., M.P.H., and Paola N. Lichtenberger, M.D.
In response to the growing presence of tropical diseases in South Florida, University of Miami physicians in the Department of Medicine’s Division of Infectious Diseases and Tropical Medicine Program have started an exchange initiative that gives students, residents, and fellows first-hand exposure to medicine in Latin America and the Caribbean, where diseases such as dengue, malaria, and chikungunya are more prevalent.
“UM sits at the gateway to the Americas, and we have all the resources in our backyard to train new crops of doctors in diagnosing and treating tropical diseases, which are increasingly surfacing in South Florida,” said Paola N. Lichtenberger, M.D., assistant professor of clinical medicine and Director of the Tropical Disease Program. Lichtenberger spearheaded the program with Susanne Doblecki-Lewis, M.D., assistant professor of medicine, and general internal medicine research fellow, Aileen Y. Chang, M.D.
Read more about the exchange program »
Jamie Barkin, M.D., William Burns, M.D., Bryan Stepanenko, M.D., M.P. H., Alexander Kaplan, M.D., M.P.H., Eric Kumetz, M.D., and Pascal J. Goldschmidt, M.D.
Less than an hour after formally receiving their Doctor of Medicine degrees during Commencement on May 9, four Miller School of Medicine graduates stepped forward to complete another commitment. They were sworn into the United States military to continue their medical training as members of the armed forces.
The newly minted doctors, Alexander Kaplan, William Burns, Bryan Stepanenko, and Erik Kumetz, were sworn in during a ceremony before proud family and friends at the Fieldhouse at the BankUnited Center.
Read more about the ceremony »
At rear, Per-Olof Berggren, Ph.D., and Midhat H. Abdulreda, Ph.D.
A research team led by Professor Per-Olof Berggren, Ph.D., an adjunct Professor and Mary Lou Held Chair at the Diabetes Research Institute at the University of Miami Miller School of Medicine and director of the Rolf Luft Research Center for Diabetes and Endocrinology at Karolinska Institutet in Stockholm, and visiting Professor at the Lee Kong Chian School of Medicine, Nanyang Technological University in Singapore, has revealed new evidence in mice on a mechanism that contributes to failure and death of the insulin-producing beta cells during development of diabetes. The study is published in the Proceedings of the National Academy of Science (PNAS).
Ten years ago, the same team discovered that apolipoprotein CIII (apoCIII) is elevated in the blood of type 1 diabetes patients which produces excessive activation of certain calcium channels in the beta cells, causing their failure to release insulin and eventual death. In this recent study, the team in collaboration with Midhat H. Abdulreda, Ph.D., assistant professor of surgery at the Miller School’s Diabetes Research Institute, now shows that apoCIII is also involved in type 2 diabetes and that the effect of apoCIII can be prevented by blocking the affected calcium channels. This may guide new therapeutic interventions to prevent beta cell deterioration during disease progression in both type 1 and type 2 diabetes.
Read more about the research »
Raul D. Mitrani, M.D., left, and Abdulla A. Damluji, M.D., M.P.H.
Atrial fibrillation (AF) remains the most common cardiac arrhythmia particularly among the elderly population. The incidence of “new-onset” AF increases with age, coronary artery disease, and systolic heart failure. In contrast to paroxysmal atrial fibrillation, “new-onset” atrial fibrillation is defined as a first episode of atrial fibrillation, without prior episodes at any time in the past, documented by an ECG or rhythm strip, physician, or patient report.
The American College of Cardiology/American Heart Association/European Society of Cardiology 2006 Guidelines for the management of patients with atrial fibrillation emphasized that clinicians should recognize the first detected episode of atrial fibrillation. However, the 2014 guidelines did not include this mandate to recognize a first episode, suggesting a lack of data regarding specific treatment for patients with the first detected episode of AF. Further, patients with new onset AF are significantly less likely to get anticoagulated than patients with prior atrial fibrillation, despite the presence of stroke risk factors.
Read more about the research »
From left, Guillermo "Willy" Prado, Ph.D., Hilda M. Pantin, Ph.D., professor and Executive Vice Chair of the Department of Public Health Sciences, Seth J. Schwartz, Ph.D., Mark Stoutenberg, Ph.D., M.S.P.H., research assistant professor, and Ric Brown, Ph.D., associate professor and Director of Implementation Science.
Given that the leading causes of death in the U.S. are preventable, the University of Miami’s Department of Public Health Sciences’ Division of Prevention Science and Community Health has recently launched a unique doctoral degree program in Prevention Science and Community Health. The aim of the new Ph.D. program is to cultivate scientists who will devise and evaluate preventive health mechanisms and arm communities with knowledge and awareness that will, in turn, decrease disease and morbidity.
“This new and exciting program will essentially train new generations of researchers who are committed to reducing health epidemics — some of which are fatal and many of which are preventable,” said Guillermo “Willy” Prado, Ph.D., M.S., Leonard M. Miller Professor of Public Health Sciences and Director of the Division of Prevention Science and Community Health.
Read more on Public Health's new Ph.D program »
From left, Rachita Sood and Michelle Picon.
Third-year medical students Rachita Sood and Michelle Picon are among this year’s record-high nine University of Miami students selected for U.S. Fulbright study grants.
Fulbright students travel to foreign countries to undertake an individually designed study/research or artistic project and teach English. They live, meet, work and learn with the people of their host countries.
Read more about the student Fulbright awards »
In support of National Clean Air Month — and a more sustainable environment — Green U encourages all UM commuters to take South Florida Commuter Services’ Clean Air Challenge. Commuters who pledge to carpool, ride transit, vanpool, bicycle or walk at least once this May will be entered into a drawing to win one of four $500 Visa gift cards. Click here for more information.